Researcher Profile Statistics: Ivan Yu Jun Seah
Geo Map
Region
#
NA - North America
7
AS - Asia, other
6
EU - Europe
2
Unknown
3
Total
18
Country
#
US - United States of America
7
SG - Singapore
4
CN - China
2
DE - Germany
2
Unknown
3
Total
18
City
#
Goleta
3
Singapore
3
Nanjing
2
Aachen
1
Dallas
1
New York
1
Ratingen
1
Santa Barbara
1
Unknown
5
Total
18
Bitstream
Downloads
ID: 1442897 - Surgical Transplantation of Human RPE Stem Cell-Derived RPE Monolayers into Non-Human Primates with Immunosuppression.pdf - ITEM:( 10635/206731)
14
Total: {0}
14
Most bitstream per type viewed
#
ID: other -
0
ID: journal -
14
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
14
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2021
0 0
0 0 0 0
0 0 0 0
1 0
1
2022
0 0
0 0 1 0
1 0 4 0
1 1
8
2023
1 0
0 0 1 1
0 3 1 1
0 0
8
2024
0 0
1 0 0 0
0 0 0 0
0 0
1
Ever
18
Geo Map
Region | # |
---|---|
NA - North America | 7 |
AS - Asia, other | 6 |
EU - Europe | 2 |
Unknown | 3 |
Total | 18 |
Country | # |
---|---|
US - United States of America | 7 |
SG - Singapore | 4 |
CN - China | 2 |
DE - Germany | 2 |
Unknown | 3 |
Total | 18 |
City | # |
---|---|
Goleta | 3 |
Singapore | 3 |
Nanjing | 2 |
Aachen | 1 |
Dallas | 1 |
New York | 1 |
Ratingen | 1 |
Santa Barbara | 1 |
Unknown | 5 |
Total | 18 |
Bitstream | Downloads |
---|---|
ID: 1442897 - Surgical Transplantation of Human RPE Stem Cell-Derived RPE Monolayers into Non-Human Primates with Immunosuppression.pdf - ITEM:( 10635/206731) | 14 |
Total: {0} | 14 |
Most bitstream per type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 14 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: allItems - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 14 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
2022 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 4 | 0 | 1 | 1 | 8 |
2023 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 3 | 1 | 1 | 0 | 0 | 8 |
2024 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Ever | 18 |